Oral
Preclinical only
Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: AMPK activation, glucose metabolism, and vascular function
Also known as: ATX-304
O304 (ATX-304) is an investigational pan-AMPK activator. A 28-day exploratory trial in people with type 2 diabetes studied 1,000 mg/day; the primary fasting-plasma-glucose endpoint was not statistically significant, although exploratory secondary signals were reported.
Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.
Data source: Primary literature and authoritative identity records
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
1000 mg daily
Context: exploratory type 2 diabetes trial PMID 29925691
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Non-human or laboratory exposure. It cannot be converted into a human dose.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.
Cross-reference catalog inclusion confirmed; sales-page dosing was not promoted to a verified protocol without traceable primary evidence.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.